Ozempic: What It Is, How It Works, Uses, and Side Effects

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This explainer is part of the PlexusDx Education Hub, our resource on GLP-1 therapies and the genetics behind metabolic decisions. Browse all Peptides & GLP-1 education.

"What is Ozempic" is a foundational question, and the honest answer starts with a molecule rather than a marketing story. This page defines the drug, explains the pathway it acts on, lays out what it treats, notes the side effects, and puts the cost landscape in context as of April 2026 — then connects it to the genetics that sit beneath the whole picture. Taken in that order, the answer to what Ozempic is becomes something you can actually use rather than a one-line label.

What Ozempic is

Ozempic is Novo Nordisk's brand of semaglutide, a GLP-1 receptor agonist that is FDA-approved for type 2 diabetes, while the same molecule appears as Rybelsus for type 2 diabetes and Wegovy for chronic weight management. Semaglutide is a modified version of native human GLP-1, engineered to resist DPP-4 degradation so it delivers sustained GLP-1 receptor engagement at therapeutic doses instead of being cleared within minutes like the natural hormone.

How it engages the GLP-1 pathway

GLP-1 receptor agonists engage the GLP-1 receptor across the pancreas, hypothalamus, and gastrointestinal tract. The results are slower gastric emptying, blunted post-meal glucose excursions, reduced appetite, and stronger satiety signaling. GIP/GLP-1 dual agonists such as tirzepatide add a second incretin mechanism by also engaging the GIP receptor. Depending on the compound, dosing is weekly or daily, and the aim is steady receptor engagement rather than a brief spike.

What it treats

FDA-approved indications across the class include type 2 diabetes for most compounds, chronic weight management for products like Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for several products, and obstructive sleep apnea in adults with obesity for Zepbound as of 2024. Prescribing matches the brand's FDA-approved indication, and the same molecule under a different brand is not automatically interchangeable for insurance or coverage purposes.

Common and rare side effects

Gastrointestinal symptoms — nausea, vomiting, diarrhea, constipation — are the most commonly reported effects and are typically most pronounced during dose titration. All FDA-approved GLP-1 compounds carry the class boxed warning for thyroid C-cell tumor risk observed in rodent studies. Rare serious events include pancreatitis, gallbladder disease, and acute kidney injury in the context of dehydration. A provider weighs these against your history before prescribing.

What it costs

Manufacturer list prices for FDA-approved branded products in this class typically run $800 to $1,600 per month at U.S. list as of April 2026. Out-of-pocket cost depends on insurance coverage, the FDA indication on the prescription, manufacturer savings card eligibility, and whether a compounded alternative is available through a licensed 503A pharmacy pathway.

The genetics beneath the definition

Understanding what Ozempic is also means understanding the biology it acts on. Variants in FTO, GLP1R, and MC4R help shape baseline GLP-1 signaling, appetite regulation, and energy balance. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, offering pathway-level context that never predicts response to a specific medication. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols.

How to think about it beyond the label

Once the definition is clear, it helps to place Ozempic within a larger family rather than treating it as a standalone product. It is one brand of one molecule, semaglutide, which itself sits inside a broader class of GLP-1 and dual-incretin therapies. Understanding that hierarchy makes news headlines, product comparisons, and coverage rules far easier to parse, because most of them are really talking about the class or the molecule rather than the single brand.

It also reframes the common question of whether Ozempic "works." The molecule reliably engages a pathway; how much that translates into an individual's results depends on compound, dose, adherence, and personal biology. Keeping the definition and the individual variation separate prevents the two most common misunderstandings, one that expects a guaranteed outcome and one that dismisses a real mechanism. With that distinction in hand, the rest of the details, from indications to cost, tend to fall into place more easily.

Frequently Asked Questions

What kind of drug is Ozempic?

It is a GLP-1 receptor agonist, the brand name for semaglutide from Novo Nordisk. Semaglutide is a modified version of native human GLP-1, engineered to resist DPP-4 degradation so it sustains GLP-1 receptor engagement at therapeutic doses rather than clearing within minutes like the natural hormone does.

How does Ozempic actually work?

It engages the GLP-1 receptor across the pancreas, hypothalamus, and gut, slowing gastric emptying, blunting post-meal glucose excursions, reducing appetite, and increasing satiety signaling. Dosing, weekly or daily by compound, delivers sustained engagement. Effects on weight and A1C vary by compound and dose per clinical trial data.

Can a genetic test tell me what Ozempic will do for me?

No. The Precision Peptide Genetic Test does not predict response to Ozempic or any medication. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology, giving you and your provider upstream context rather than a prediction.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.